Replies to post #71425 on Biotech Values

[DewDiligence]

NTMD – Pretty simple, Deerfield doesn't view merging with Archemix as appealing and would rather see them liquidate.

I understand that part. What I don’t understand is how they figure on getting more than 65 cents of value from a liquidation.